Elias, E., Krishnan, S., Oketola, A., Singh, H., Bernstein, C. N., & Targownik, L. (2019). A132 ANTI-TNF DOSE AUGMENTATION FREQUENTLY OCCURS IN THE ABSENCE OF OBJECTIVE EVIDENCE OF DISEASE ACTIVITY. J Can Assoc Gastroenterol.
Styl ChicagoElias, E., S. Krishnan, A. Oketola, H. Singh, C N. Bernstein, a L. Targownik. "A132 ANTI-TNF DOSE AUGMENTATION FREQUENTLY OCCURS IN THE ABSENCE OF OBJECTIVE EVIDENCE OF DISEASE ACTIVITY." J Can Assoc Gastroenterol 2019.
Citace podle MLAElias, E., et al. "A132 ANTI-TNF DOSE AUGMENTATION FREQUENTLY OCCURS IN THE ABSENCE OF OBJECTIVE EVIDENCE OF DISEASE ACTIVITY." J Can Assoc Gastroenterol 2019.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..